Slide Presentations

National Institutes of Health
Slide Presentation on the Privacy Rule and Research

---

Slide 27:

< Previous	Slide 27	Next >
IRB/Privacy Board Criteria for Waiving or Altering Authorization

The use or disclosure involves no more than minimal risk because of an adequate plan/assurance:	Yes	No
To protect identifiers from improper use or disclosure.	Yes	No
To destroy identifiers at earliest opportunity, consistent with the conduct of the research.	Yes	No
That PHI will not be inappropriately reused or disclosed.	Yes	No
The research could not practicably be conducted without the waiver or alteration.	Yes	No
The research could not practicably be conducted without access to and use of PHI.	Yes	No
Signature of IRB/Privacy Board Chair (or Designee)               Date